Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Li

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinomaAndrew J Li, Rae Lynn Baldwin, Beth Y Karlan
Gynecologic Oncology|September 15, 2010
Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cellsBarbie Taylor-Harding, Sandra Orsulic, Beth Y Karlan, et al.
Gynecologic Oncology|June 10, 2017
Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancerTilley Jenkins Vogel, Marc T Goodman, Andrew J Li, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2022
Acetylcholinesterase Inhibition Assays for High-Throughput ScreeningShuaizhang Li, Andrew J Li, Jinghua Zhao, et al.
Gynecologic Oncology|September 11, 2007
Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biologyAndrew J Li, R Geoffrey Elmore, James C Pavelka, et al.
The Journal of Reproductive Medicine|August 28, 2010
Effect of cigarette smoking on epithelial ovarian cancer survivalYevgeniya J M Ioffe, R Geoffrey Elmore, Beth Y Karlan, et al.
Gynecologic Oncology|October 14, 2009
Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancersAndrew J Li, R Geoffrey Elmore, Ida Yii-der Chen, et al.
Gynecologic Oncology|April 1, 2008
Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomasAndrew J Li, Daniel R Scoles, Klara U M Armstrong, et al.
Gynecologic Oncology Reports|September 19, 2018
Sebaceous carcinoma arising within an ovarian mature cystic teratoma: A case report with discussion of clinical management and genetic evaluationAlyssa Wield, Melissa Hodeib, Mohammad Khan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
AIB1 polymorphisms predict aggressive ovarian cancer phenotypeAndrew J Li, Dimitry L Lerner, Maria-Emily R Gapuzan, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinomaAndrew J Li, Rae Lynn Baldwin, Beth Y Karlan
Gynecologic Oncology|September 15, 2010
Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cellsBarbie Taylor-Harding, Sandra Orsulic, Beth Y Karlan, et al.
Gynecologic Oncology|June 10, 2017
Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancerTilley Jenkins Vogel, Marc T Goodman, Andrew J Li, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2022
Acetylcholinesterase Inhibition Assays for High-Throughput ScreeningShuaizhang Li, Andrew J Li, Jinghua Zhao, et al.
Gynecologic Oncology|September 11, 2007
Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biologyAndrew J Li, R Geoffrey Elmore, James C Pavelka, et al.
The Journal of Reproductive Medicine|August 28, 2010
Effect of cigarette smoking on epithelial ovarian cancer survivalYevgeniya J M Ioffe, R Geoffrey Elmore, Beth Y Karlan, et al.
Gynecologic Oncology|October 14, 2009
Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancersAndrew J Li, R Geoffrey Elmore, Ida Yii-der Chen, et al.
Gynecologic Oncology|April 1, 2008
Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomasAndrew J Li, Daniel R Scoles, Klara U M Armstrong, et al.
Gynecologic Oncology Reports|September 19, 2018
Sebaceous carcinoma arising within an ovarian mature cystic teratoma: A case report with discussion of clinical management and genetic evaluationAlyssa Wield, Melissa Hodeib, Mohammad Khan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
AIB1 polymorphisms predict aggressive ovarian cancer phenotypeAndrew J Li, Dimitry L Lerner, Maria-Emily R Gapuzan, et al.
Pageof 6